During one of those early screenings, the audience watched the screen in horror as a locomotive appeared to advance towards them. Fearing that the train would hit them they leapt from their seats and into the aisles.

Although the reaction is both understandable and – in retrospect – charming, the historically interesting aspect is how willing people were to be part of a movement (quite literally). In essence, they wanted to ‘witness history’.

The ‘future’, as with so many pivotal episodes in history, is not some unimaginably advanced time period. In reality, it is often centred in the present. The here, the now.

UK pharma and life sciences are a totemic symbol of that glorious future, but parts of wider healthcare lurch around hopelessly deferential to the past. The NHS has only just phased out fax machines. I’ll allow you to process that for a while.

In a way the fax machine is a perfect metaphor for public health systems. Well-meaning but utterly unreliable.

The key for a reboot in which pharma, the NHS and patients have a slick, symbiotic relationship is a fluid system design that embraces innovators, inter-sector visionaries, start-ups and, yes, big tech.

As a nation we must reshape the NHS and that means taking courage. It means, stepping into the theatre of dreams and becoming part of history.

Enjoy the mag,

John Pinching
editor

PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com Twitter: @PharmaTimes

EDITORIAL
John Pinching / editor
john.pinching@pharmatimes.com

Iona Everson / group managing editor
iona.everson@pharmatimes.com

Karl Equi / executive director
karl.equi@pharmatimes.com  

SALES & MARKETING
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com

Luci Sargood / business manager
luci.sargood@pharmatimes.com

SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK and £100.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2023 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.